Marc D Beer bought $417K of biote (BTMD)
Executed Mar 17 2025, disclosed Mar 18 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Mar 18 2025), the stock returned -20.1% (delay-adjusted); from the execution session (Mar 17 2025), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.
Marc D Beer (Executive Chairman) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in biote Corp. (BTMD). Across 1 priced purchase filing, the average 21-session return was +0.0% from execution and -15.5% from disclosure (delay-adjusted; derived). The largest single filing was $177K of BTMD (115,950 sh × $1.53, as filed), executed Aug 10.
Healthcare · biote Corp. operates in practice-building business within the hormone optimization space
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→115,950 sh × $1.53
Exec Aug 10
Filed Aug 12 · 4:25 PM ET